The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix

被引:323
作者
Zhu, Hui
Mitsuhashi, Noboru
Klein, Andrew
Barsky, Lora W.
Weinberg, Kenneth
Barr, Mark L.
Demetriou, Achilles
Wu, Gordon D.
机构
[1] Cedars Sinai Med Ctr, Dept Surg, Comprehens Transplant Ctr, Los Angeles, CA 90048 USA
[2] Childrens Hosp Los Angeles, Div Res Immunol & Bone Marrow Transplantat, Saban Res Inst, Los Angeles, CA 90027 USA
关键词
CD44; hyaluronan; platelet-derived growth factor; mesenchymal stem cell; cell migration;
D O I
10.1634/stemcells.2005-0186
中图分类号
Q813 [细胞工程];
学科分类号
摘要
In a previous investigation, we demonstrated that mesenchymal stem cells (MSCs) actively migrated to cardiac allografts and contributed to graft fibrosis and, to a lesser extent, to myocardial regeneration. The cellular/molecular mechanism responsible for MSC migration, however, is poorly understood. This paper examines the role of CD44-hyaluronan interaction in MSC migration, using a rat MSC line Ap8c3 and mouse CD44(-/-) or CD44(+/+) bone marrow stromal cells (BMSCs). Platelet-derived growth factor (PDGF) stimulation of MSC Ap8c3 cells significantly increased the levels of cell surface. CD44 detected by flow cytometry. The CD44 standard isoform was predominantly expressed by Ap8c3 cells, accounting for 90% of the CD44 mRNA determined by quantitative real-time polymerase chain reaction. Mouse CD44(-/-) BMSCs bonded inefficiently to hyaluronic acid (HA), whereas CD44(+/+) BMSC and MSC Ap8c3 adhered strongly to HA. Adhesions of MSC Ap8c3 cells to HA were suppressed by anti-CD44 antibody and by CD44 small interfering RNA (siRNA). HA coating of the migration chamber significantly promoted passage of CD44(+/+) BMSC or Ap8c3 cells, but not CD44(-/-) BMSCs, through the insert membranes (p < .10). Migration of MSC Ap8c3 was significantly inhibited by anti-CD44 antibodies (p < .01) and to a lesser extent by CD44 siRNA (p = .05). The data indicate that MSC Ap8c3 cells, in response to PDGF stimulation, express high levels of CD44 standard (CD44s) isoform, which facilitates cell migration through interaction with extracellular HA. Such a migratory mechanism could be critical for recruitment of MSCs into wound sites for the proposition of tissue regeneration, as well as for migration of fibroblast progenitors to allografts in the development of graft fibrosis.
引用
收藏
页码:928 / 935
页数:8
相关论文
共 32 条
[1]   Platelet-derived growth factor-induced formation of tensin and phosphoinositide 3-kinase complexes [J].
Auger, KR ;
Zhou, SY ;
Lo, SH ;
Roberts, TM ;
Chen, LB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (38) :23452-23457
[2]   CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow [J].
Avigdor, A ;
Goichberg, P ;
Shivtiel, S ;
Dar, A ;
Peled, A ;
Samira, S ;
Kollet, O ;
Hershkoviz, R ;
Alon, R ;
Hardan, I ;
Ben-Hur, H ;
Naor, D ;
Nagler, A ;
Lapidot, T .
BLOOD, 2004, 103 (08) :2981-2989
[3]  
Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO
[4]  
2-7
[5]   The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue [J].
Beljaars, L ;
Weert, B ;
Geerts, A ;
Meijer, DKF ;
Poelstra, K .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (07) :1307-1317
[6]  
BILLINGHAM ME, 1992, J HEART LUNG TRANSPL, V11, pS38
[7]  
DeGrendele HC, 1997, J IMMUNOL, V159, P2549
[8]   CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells [J].
Draffin, JE ;
McFarlane, S ;
Hill, A ;
Johnston, PG ;
Waugh, DJJ .
CANCER RESEARCH, 2004, 64 (16) :5702-5711
[9]   CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix [J].
Henke, CA ;
Roongta, U ;
Mickelson, DJ ;
Knutson, JR ;
McCarthy, JB .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) :2541-2552
[10]   EXPERIENCES WITH RENAL HOMOTRANSPLANTATION IN THE HUMAN - REPORT OF 9 CASES [J].
HUME, DM ;
MERRILL, JP ;
MILLER, BF ;
THORN, GW .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (02) :327-382